News
Charles Rudin, MD, PhD
Dr. Rudin is the Sylvia Hassenfeld Professor and Chief of Thoracic Oncology at Memorial Sloan Kettering Cancer Center in New York, where he also co-directs the Druckenmiller Center for Lung Cancer Research. Charlie oversees a broad and integrated program of preclinical and clinical research in lung cancer, spanning from basic discovery science, preclinical modeling and…
Paresh Vyas, MRCP FRCP FRCPath
Paresh Vyas, MRCP FRCP FRCPath, is a Professor of Haematology at Oxford University. He studied medicine at Cambridge then Oxford. After completing his medical and haematology training in London. He did his PhD with Professor Higgs and Professor Sir Weatherall at the MRC Molecular Haematology Unit, Oxford and did a three years doing a post-doctoral…
Matthew Vander Heiden, MD, PhD
Matthew Vander Heiden, M.D., Ph.D., is an Associate Professor in the Department of Biology at the Massachusetts Institute of Technology, and Associate Director of the Koch Institute for Integrative Cancer Research. He is also an HHMI Faculty Scholar, an Institute Member of the Broad Institute of Harvard and MIT, and an Instructor of Medicine at…
George Thomas, MD
Dr. George Thomas is a professor of pathology at the Knight Cancer Institute, Oregon Health & Science University in Portland, Oregon. He is also associate medical director of the Knight Diagnostics Laboratory. His clinical area of expertise is in precision oncology of prostate and kidney cancers. He directs a translational research program that studies treatment…
Shin-San Michael Su, PhD
Dr. Michael Su joined Volastra as Chief Scientific Officer in February 2020. Previously, he served as CSO of Decibel Therapeutics, a gene therapy company focused on hearing loss and imbalance between 2016 and 2020. Michael was a co-founder and Senior Vice President of Research and Development at Agios Pharmaceuticals between 2008 and 2016. During his…
Eytan Stein, MD
Eytan M. Stein, MD is an Associate Attending Physician, Clinical Investigator and Director of the Program for Drug Development in Leukemia on the Leukemia Service at Memorial Sloan Kettering Cancer Center. He conducts novel, phase I clinical trials of compounds that target the genetic and epigenetic basis of myeloid malignancies. Dr. Stein led the clinical…
Kimberly Stegmaier, MD
Kimberly Stegmaier, MD, Professor of Pediatrics at Harvard Medical School and the Ted Williams Chair at Dana-Farber Cancer Institute, has advanced the application of genomics to drug and protein target discovery for pediatric malignancies. She is the Vice Chair for Pediatric Oncology Research, Co-director of the Pediatric Hematologic Malignancy Program, and an attending physician providing…
Mikhail (Misha) Roshal, MD, PhD
Misha Roshal is a practicing hematopathologist, associate attending physician, and director of the clinical flow cytometry laboratory in the department of pathology in Memorial Sloan Kettering Cancer Center. His major clinical expertise is in development of robust flow cytometry-based assays for assessment of treatment response of hematologic neoplasms. His laboratory has developed assays for high sensitivity…